Navigation Links
Merck's Pain Reliever Arcoxia Rejected by US Federal Advisory Panel

An advisory panel of the United States Food and Drug Administration (FDA) has rejected pharmaceutical giant Merck's bid to market Arcoxia,// a new osteoarthritis medication following concerns that it may carry cardiovascular risks.

Osteoarthritis is a joint disease that mostly affects cartilage. Cartilage is the slippery tissue that covers the ends of bones in a joint.

While healthy cartilage allows bones to glide over each other and helps absorb shock of movement, in osteoarthritis, the top layer of cartilage breaks down and wears away.

This allows bones under the cartilage to rub together. The rubbing causes pain, swelling, and loss of motion of the joint.

Merck's Arcoxia is in the class of non-steroidal anti-inflammatory drugs (NSAIDs) known as COX-2 inhibitors.

It had to pull yet another CoX-2 inhibitor Vioxx from the US market in 2004, also following evidence that it increased the patients' risk of heart attacks and strokes.

G.D.Searle and Company too withdrew a COX-2 inhibitor, Bextra because of similar concerns.

These newly developed drugs for treatment of inflammation selectively block an enzyme called COX-2. Blocking this enzyme impedes the production of the chemical messengers (prostaglandins) that cause the pain and swelling resulting from arthritis inflammation.

And they are supposed to be gentler on the stomach, making it easier for patients than traditional pain relievers. But then one has to contend with serious side-effects.

The FDA advisory panel on Thursday rejected by a 20-to-1 margin the Merck's new formulation, Arcoxia.

"We got what appears to be a very clear vote advising us against approval," said Robert Meyer, director of FDA's office of drug evaluation.

Dr. David Graham, a leading critic of the now withdrawn Vioxx, told the panel that Arcoxia might increase substantially the risk of stroke and heart attack and was no more e
'"/>




Page: 1 2

Related medicine news :

1. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
2. Ranbaxy in Fray to Buy Mercks Generic Drugs Unit
3. The Effect Of Pain Relievers In Treating Kids With Migraine Questioned
4. Hypnotherapy can be a Pain Reliever
5. FDA Proposes Stringent Warnings Labels for Pain Relievers
6. Arcoxia Slammed –Nothing Better Than Vioxx Says FD
7. Testosterone patch for women Rejected For safety Reasons
8. Federal Government Has to do a lot to prevent spread of HIV
9. New Study Conducted To Evaluate The Success Of The Federal governments Funds For HIV/AIDS
10. Sunscreen Blocking UVA Radiation Receives Federal Approval
11. Imperative to Extend Reach of Federal Health Insurance Schemes for children
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Merck Pain Reliever Arcoxia Rejected Federal Advisory Panel

(Date:6/30/2015)... , ... June 30, 2015 , ... White Blitz ... expanding its suite of products to mobile teeth whitening entrepreneurs. Mobile teeth whitening is ... that offer convenience and a personal touch. The popularity of the industry has spawn ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Ticket Down is a reputable source of ... native of Detroit, MI, Kid Rock, is hitting the road again this summer in what ... and hip hop superstar kicked off his summer tour this year at the XFINITY Theatre ...
(Date:6/30/2015)... ... ... Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as a firm, and ... As of July 1, 2015, the firm and Mr. Brown personally have been recognized ... The award is a culmination of the hard work, long hours, and excellent results the ...
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound Care ... Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, California ... and hyperbaric medicine education and training is something that is never complete. Even ...
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has been ... Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. ... Trenton Health Team ACO draws on the collaborative structure of THT, bringing together the ...
Breaking Medicine News(10 mins):Health News:White Blitz to Develop New Mobile Teeth Whitening Program for Entrepreneurs 2Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3
... ... at ITEXPO , ... CA, ITEXPO West 2009 (PRWEB) September 3, 2009 -- FaxBack®, a leading provider of ... program for a new fax ATA device, based on HTTPS, which provides a superior level ...
... ... , ... September 3, 2009 -- Today,s challenging business environment requires companies to maximize valuable resources ... staffs, the reliance on outside consultants to accomplish these strategies becomes not just a ...
... , , PHOENIX, Sept. 2 ... southwestern United States, has formed a strategic alliance with American National ... getting claims compensated in a timely manner with a proprietary process ... , , "Over the last 10 years ...
... MONTREAL, Sept. 2 With five years and ... manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of ... products nationwide in Canada with an exclusive multimillion-dollar agreement ... Patterson has operations in Vancouver, Edmonton, Calgary, London, Toronto, ...
... , , , ... Martek Biosciences Corporation (Nasdaq: MATK ) today announced its financial results ... $77.8 million, down 12% from $88.4 million in the third quarter of fiscal ... third quarter of fiscal 2009, a 4% decrease compared with $9.3 million, or ...
... , NEW YORK , Sept. 2 In the ... don,t have to shout to be heard. A pioneer in the eHealth ... online call for a careful, strategic approach to reform is attracting the ... as everyday Americans currently struggling to pay their medical bills. , ...
Cached Medicine News:Health News:FaxBack Announces a New VoIP Fax ATA, based on HTTPS, Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 2Health News:Find Qualified Consulting Firms Quickly and Efficiently 2Health News:Find Qualified Consulting Firms Quickly and Efficiently 3Health News:ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 2Health News:Martek Announces Third Quarter 2009 Financial Results 2Health News:Martek Announces Third Quarter 2009 Financial Results 3Health News:Martek Announces Third Quarter 2009 Financial Results 4Health News:Martek Announces Third Quarter 2009 Financial Results 5Health News:Martek Announces Third Quarter 2009 Financial Results 6Health News:Martek Announces Third Quarter 2009 Financial Results 7Health News:Martek Announces Third Quarter 2009 Financial Results 8Health News:Martek Announces Third Quarter 2009 Financial Results 9Health News:Martek Announces Third Quarter 2009 Financial Results 10Health News:Martek Announces Third Quarter 2009 Financial Results 11Health News:Martek Announces Third Quarter 2009 Financial Results 12Health News:Healthcare Debate: One Citizen's Call for Calm Catches On 2
(Date:6/30/2015)... 30, 2015 Velos, Inc., the pioneering software ... grow and add customers who receive Clinical and Translational ... CTSAs awarded by the National Institutes of Health currently ... is among the largest such market shares in its ... CTSA community keeps growing as a result of our ...
(Date:6/30/2015)... , June 30, 2015   Millar, Inc. ... technology, today announced the 2016 retirement of Craig ... Directors, after 12 years of service to the Company. ... named two senior members of the Executive Management team ... Tim Daugherty , currently Director of Sales and ...
(Date:6/30/2015)... , June 30, 2015 Olympus, ... innovative solutions for medical and surgical procedures, among ... next-day replacements for surgical equipment at no additional ... to offer this type of guarantee. The service ... Service Agreement earlier this year. ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
... 7, 2010 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... Review meeting with the U.S. Food and Drug Administration (FDA) ... the Company,s New Drug Application (NDA) for AZ-004 ( Staccato ... FDA in preparation for the meeting, with the responses or ...
... Dec. 7, 2010 Apexigen, Inc. announced today ... worldwide license agreement with Centocor Research & Development, ... therapeutic antibody technologies to discover and develop monoclonal ... to several targets specified by Centocor R&D, which ...
Cached Medicine Technology:Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 2Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 3Apexigen, Inc. Announces Collaboration for Antibody Discovery 2
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: